Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Financial Officer
-
Stock Symbol
-
RCUS on NYSE
Robert Goeltz II - trading volume in the past year for Arcus Biosciences, Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common Stock |
63.7K |
$1.02M |
$16.08 |
Dec 15, 2024 |
Direct |
|
|
Stock Option (right to buy) |
86.6K |
|
|
Jan 23, 2024 |
Direct |
Common Stock |
|
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.